Carcinoembryonic antigen-related cell adhesion molecule pseudogene 9 (CEACAMP9)

Carcinoembryonic antigen-related cell adhesion molecule pseudogene 9 (CEACAMP9) is a non-protein-coding pseudogene within the CEACAM subfamily, located among other CEA family genes on human chromosome 19q13.2. The CEA gene family consists of both protein-coding genes involved in cell adhesion, immune modulation, and cancer, as well as numerous pseudogenes that do not produce functional proteins. CEACAMP9 lacks evidence of translation into a functional protein and is not associated with molecular processes relevant to cell signaling, disease, or therapeutic intervention[1][4]. The numerous alternative names reflect historical gene family nomenclature; modern practice recognizes CEACAMP9 as a pseudogene rather than a functional receptor or adhesion molecule. Key distinctions: - Not a therapeutic target or functional receptor. - No known biological activity. - No evidence of clinical significance. - Included in gene lists due to clustering and evolutionary history, not functional relevance. If you require information about functionally relevant CEACAM proteins (such as CEACAM1, CEACAM5, CEACAM6), those are distinct protein-coding targets frequently studied in cancer, immunology, and cell biology for their cell adhesion and signaling roles[2][3][4].

Other names

CEACAM30PCGM16Carcinoembryonic antigen gene family member 16Carcinoembryonic antigen related cell adhesion molecule pseudogene 9Carcinoembryonic antigen-related cell adhesion molecule 30, pseudogenePregnancy-specific beta-1-glycoprotein 9 pseudogeneCEACAMP9

None. No drugs act upon it; pseudogenes do not participate in molecular pharmacology